FDA Revitalization Bill Progresses In Senate

Law360, New York (April 19, 2007, 12:00 AM EDT) -- A Senate Committee approved a bill Wednesday that would require the U.S. Food and Drug Administration to monitor safety of new drugs and renew a law allowing the agency to collect fees from drug companies and medical device manufacturers.

The bill, sponsored by Sens. Edward Kennedy (D-Mass.) and Michael Enzi (R-Wyo.) the chairman and ranking member of the Senate Health, Education, Labor and Pensions Committee, passed by a 15-5 vote.

The Prescription Drug User Fee Act, which allows the FDA to charge user fees for such...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.